INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED Innovative Pharmaceutical Biotech Limited
Equities
399
BMG4783W1073
Industrial Machinery & Equipment
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.199 HKD | 0.00% |
|
-0.50% | -9.13% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Innovative Pharmaceutical Biotech Limited is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The Company operates through five segments. Genetic Testing Services segment is engaged in the provision of genetic testing services in the Peopleâs Republic of China (PRC) and Hong Kong. Bio-Industrial Products segment is engaged in the distribution of bio-industrial products in the PRC. Beauty Equipment and Products segment is engaged in the trading of beauty equipment and products in Hong Kong. Securities Investment segment is engaged in securities investment in Hong Kong and outside Hong Kong. Research and Development segment is engaged in the research, development and commercialization of the oral insulin products.
Calendar
2024-06-27
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.13% | 43.8M | |
| +12.14% | 45.6B | |
| +5.25% | 39.03B | |
| +4.75% | 6.99B | |
| +0.95% | 6.04B | |
| -7.94% | 5.25B | |
| +29.24% | 1.59B | |
| +4.63% | 1.55B | |
| -12.73% | 1.17B | |
| +3.80% | 1.06B |
- Stock Market
- Equities
- 399 Stock
- News Innovative Pharmaceutical Biotech Limited
- Innovative Pharmaceutical Biotech Incurs Loss in Fiscal Year 2023
